Alector shares plunge after dementia drug fails to slow disease progression – Reuters

Written by

admin

in

  1. Alector shares plunge after dementia drug fails to slow disease progression  Reuters
  2. Alector’s dementia drug fails to slow patient decline in late-stage trial  statnews.com
  3. Alector Announces Results from its Phase 3 Clinical Trial of Potential FTD-GRN Therapeutic  Yahoo Finance
  4. Alector announces topline results from latozinemab phase 3 trial in individuals with frontotemporal dementia due to a GRN mutation and provides business update  MarketScreener
  5. Peninsula biotech to lay off nearly half its staff after dementia drug fails in clinical trial  The Business Journals

Continue Reading

More posts